Analysen von Keyur Parekh
| 02.03.23 | GSK Buy | Goldman Sachs Group Inc. | |
| 02.03.23 | Merck Sell | Goldman Sachs Group Inc. | |
| 27.02.23 | GSK Buy | Goldman Sachs Group Inc. | |
| 17.02.23 | Bayer Buy | Goldman Sachs Group Inc. | |
| 13.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.02.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.02.23 | Sanofi Buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 10.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.23 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | Bayer Buy | Goldman Sachs Group Inc. | |
| 07.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.23 | Merck Sell | Goldman Sachs Group Inc. | |
| 03.02.23 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.23 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 25.01.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.01.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.01.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.01.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.12.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.11.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 15.11.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.11.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 03.11.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 25.10.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.10.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 11.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.09.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 20.09.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 13.09.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.22 | Sanofi Buy | Goldman Sachs Group Inc. | |